BONK, INC. Files 8-K: Director Changes, Compensation, Bylaw Amendments
Ticker: BNKK · Form: 8-K · Filed: Oct 14, 2025 · CIK: 1760903
Sentiment: neutral
Topics: corporate-governance, executive-compensation, bylaws
TL;DR
BONK, INC. 8-K: Board shakeup, comp changes, and bylaw updates filed 10/14.
AI Summary
BONK, INC. filed an 8-K on October 14, 2025, reporting several key events. These include the departure of a director, the election of a new director, and changes to executive compensation arrangements. The company also disclosed amendments to its articles of incorporation and bylaws, a change in its fiscal year, and other events under Regulation FD. Financial statements and exhibits were also filed.
Why It Matters
These filings indicate significant corporate governance and structural changes within BONK, INC., which could impact its operational direction and investor relations.
Risk Assessment
Risk Level: medium — Changes in directors, compensation, and bylaws can signal internal shifts that may affect future performance or strategy.
Key Players & Entities
- BONK, INC. (company) — Filer of the 8-K report
- October 14, 2025 (date) — Date of the 8-K filing
- October 8, 2025 (date) — Period of report for the 8-K
FAQ
Who departed from the board of directors at BONK, INC.?
The filing indicates the departure of a director, but the specific name is not detailed in the provided text.
Were there any new directors elected to BONK, INC.'s board?
Yes, the filing states that there was an election of directors.
What other significant corporate actions were reported by BONK, INC.?
BONK, INC. also reported changes to compensatory arrangements for certain officers, amendments to its articles of incorporation and bylaws, and a change in its fiscal year.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on October 14, 2025.
What is BONK, INC.'s primary industry?
BONK, INC. is in the 'PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS' industry, with SIC code 2844.
Filing Stats: 1,005 words · 4 min read · ~3 pages · Grade level 11.3 · Accepted 2025-10-14 15:45:34
Key Financial Figures
- $8.50 — isable for one share of Common Stock at $8.50 per share BNKKW The Nasdaq Stock Ma
- $0.001 — Convertible Preferred Stock, par value $0.001 per share (the " Series C Preferred Sto
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex3-1.htm (EX-3.1) — 1KB
- ex3-2.htm (EX-3.2) — 2KB
- ex99-1.htm (EX-99.1) — 11KB
- ex3-1_001.jpg (GRAPHIC) — 243KB
- ex3-2_001.jpg (GRAPHIC) — 517KB
- ex3-2_002.jpg (GRAPHIC) — 300KB
- ex3-2_003.jpg (GRAPHIC) — 50KB
- ex99-1_001.jpg (GRAPHIC) — 21KB
- 0001493152-25-018004.txt ( ) — 1840KB
- shot-20251008.xsd (EX-101.SCH) — 4KB
- shot-20251008_def.xml (EX-101.DEF) — 26KB
- shot-20251008_lab.xml (EX-101.LAB) — 37KB
- shot-20251008_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2025 BONK, INC. (Exact name of registrant as specified in charter) Delaware 001-39569 83-2455880 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 18801 N Thompson Peak Pkwy Ste 380 , Scottsdale , AZ 85255 (Address of principal executive offices) (Zip Code) (561) 244-7100 (Registrant's telephone number, including area code) Safety Shot, Inc. (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock BNKK The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Warrants, each exercisable for one share of Common Stock at $8.50 per share BNKKW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Effective as of October 10, 2025, the Board of Directors (the "Board") of Bonk, Inc. (the "Company") appointed Connor Klein as an independent member of the Board and of the Company's audit committee to serve until the Company's 2026 Annual Meeting of Stockholders. Mr. Klein will receive compensation consistent with the Company's non-executive directors. Mr. Klein does not have any family relationships with any of the Company's directors or executive officers. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Name and Symbol Change On September 16, 2025, the Board approved the change in the name of the Company to "Bonk, Inc." (the "Name Change") and the change in the trading symbol of the Company to "BNKK" on the Nasdaq Capital Market (the "Symbol Change") to align with its major transformation into a BONK strategy company. On October 8, 2025, to effectuate the Name Change, the Company filed a Certificate of Amendment of the Certificate of Incorporation of the Company, as amended and restated (the "Charter Amendment"), with the Secretary of State of the State of Delaware. The Name Change and the Symbol Change took effect on the Nasdaq Capital Market on October 10, 2025. Pursuant to Section 242(d)(1) of the Delaware General Corporation Law, no shareholder approval was required for the Charter Amendment because it only related to a name change. A copy of the Charter Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference. Neither the Name Change nor the Symbol Change affects the rights of the Company's stockholders, and stockholders do not need to take any action in connection with the Name Change or the Symbol Change. The CUSIP number for the Company's common stock and warrants remain 48208F105 and 48208F113, respectively. Series C Certificate of Designation Amendment On October 10, 2025, the Company, upon approval of the Company's Board of Directors and the sole holder of the Company's Series C Convertible Preferred Stock, par value $0.001 per share (the " Series C Preferred Stock "), filed an Amendment to the Amended and Restated Certificate of Designation of Series C Preferred Stock with the Secretary of State of the State of Delaware (the " Series C Certificate of Designation Amendment "). The Series C Certificate of Designation Amendment adds a "step-down provision" in respect of the rights granted to the holders of Series C Preferred Stock to elect members of the Board. The foregoing description of the Series C Certificate of Designation Amendment does not purport to be a complete d